Sunday, October 28
Recently published FDA-approved clinical trials demonstrated the efficacy of a single psilocybin-generated experience in helping individuals with cancer cultivate meaning, existential and spiritual well-being, and develop a greater acceptance of death’s approach.
We will present an overview of relevant scientific findings that offer hope for rapid reductions in depression, anxiety, hopelessness, and demoralization. Mystical experiences induced by psilocybin-assisted therapies represent a novel approach to alleviating suffering and promoting meaning and openness to the mystery of death.
We will invite discussion of future research issues, including the acceptability of psychedelics within black, Asian, and Latino cultures, whether and how psychedelics might enhance meaning-based therapies and opportunities for moving from psychedelic-assisted therapies from research to practice.